MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,250 | -2.3% | 25,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $33,000 | +85.9% | 25,000 | 0.0% | 0.00% | – |
Q1 2023 | $17,750 | -52.7% | 25,000 | -50.0% | 0.00% | -100.0% |
Q4 2022 | $37,500 | +70.5% | 50,000 | +100.0% | 0.00% | – |
Q3 2022 | $22,000 | -21.4% | 25,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $28,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |